The Robert Wood Johnson Foundation has named its new president and CEO. Richard Besser, MD, who will succeed Risa Lavizzo-Mourey, MD, who ran the foundation for 14 years before announcing she was stepping down in September 2016.
The Robert Wood Johnson Foundation (RWJF) has named its new president and CEO. Richard Besser, MD, who will succeed Risa Lavizzo-Mourey, MD, who ran the foundation for 14 years before announcing she was stepping down in September 2016.
Lavizzo-Mourey has remained president and CEO of RWJF and will continue to do so during the transition, with Besser expected to fully take over in April.
Besser is a former acting director for the CDC and the current chief health and medical editor at ABC News. At the CDC, Besser was responsible for the agency’s public health emergency preparedness and emergency response activities. He led the response to the H1N1 influenza pandemic in 2009.
“Richard Besser is a superb choice to lead RWJF into the next stage of our work,” Roger Fine, chairman of the foundation’s board of directors, said in a statement. “He is a smart, empathetic leader and communicator—someone who can build on the great energy we have been developing around our Culture of Health vision.”
Fine added that Lavizzo-Mourey has left “big shoes to fill,” but that he is confident Besser will bring his own wisdom to the Foundation.
Lavizzo-Mourey focused on building a Culture of Health, among other topics, during her tenure as the head of RWJF. The Culture of Health, which envisions improved health for everyone through access to healthy food, safe housing, transportation, education, and jobs, remains a focus for the Foundation.
“It is truly an honor to be selected to lead RWJF, a foundation so deeply committed to building a Culture of Health in this country,” said Besser. “Working to improve the health and well-being of all Americans is a high calling. Doing it here, with an organization of such stature and credibility will be a great honor and privilege.”
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen